News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Hagop Kantarjian: Combination of venetoclax and hypomethylating agent provides high rates of durable remission and overall survival in both newly diagnosed and R/R IDH1/2-mutated Acute Myeloid Leukemia.
Photo of Dr. Hagop Kantarjian from obroncology.com
Sep 27, 2023, 18:06

Hagop Kantarjian: Combination of venetoclax and hypomethylating agent provides high rates of durable remission and overall survival in both newly diagnosed and R/R IDH1/2-mutated Acute Myeloid Leukemia.

Quoting Hagop Kantarjian, Professor and Chair of the Department of Leukemia at MD Anderson Cancer Center, on X/Twitter:

“Combination of venetoclax and hypomethylating agent provides high rates of durable remission and overall survival in both newly diagnosed and R/R IDH1/2-mutated Acute Myeloid Leukemia.”

For details click here.
Source: Hagop Kantarjian/Twitter

 

 

Acute Myeloid Leukaemia AML cancer Hagop Kantarjian OncoDaily Oncology venetoclax
Special Coverage
Insight
Jan 15, 2025, 18:32
MD Anderson Study Reveals Integrated Care as Top Strategy for Smoking Cessation in Lung Screening
Insight
Jan 15, 2025, 18:31
Mehdi Hamadani: Current status of ADCs in lymphoma DLBCL
Blog
Jan 15, 2025, 18:25
Discussion on advancing the Global Cancer Fund at The White House - ASCO
Blog
Jan 15, 2025, 18:19
Antonio Passaro: COCOON study meets primary endpoint
Blog
Jan 15, 2025, 17:58
Felice Gorordo: The White House's round table on the creation of the Global Cancer Fund
Insight
Jan 15, 2025, 17:48
ESO announced the mentorship pairings for 2025
Insight
Jan 15, 2025, 17:38
Baris Turkbey: Impact of Endorectal Coil Use on Extraprostatic Extension Detection in Prostate MRI
Blog
Jan 15, 2025, 17:37
Shalini Rao: Delighted to chair the Gordon Research Seminar on Pancreatic Diseases in Maine
Blog
Jan 15, 2025, 17:33
Exploring the Future of HR+/HER2- MBC Treatment – Live Webinar by SPCC
Insight
Jan 15, 2025, 17:27
Integration of Generative AI into Radiation Therapy practice
Insight
Jan 15, 2025, 17:26
Ajay Major: Summary table of all studies of CAR-T in CNS lymphomas
Insight
Jan 15, 2025, 17:19
Yakup Ergün: A Perspective on the MARS2 Trial by Eric Lim et al